Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins

Journal of Feline Medicine and Surgery

Volumn 11, Issue 8, 2009, Pages 683-691

  Marshall, R D ^a,b   Rand, J S ^a   Morton, J M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b The Cat Clinic   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLARGINE; INSULIN; LONG ACTING INSULIN; PROTAMINE; PROTAMINE ZINC;

ANALYSIS OF VARIANCE; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CARBOHYDRATE DIET; CAT; CAT DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; DIET THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; MALE; METHODOLOGY; REMISSION; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD GLUCOSE; CAT DISEASES; CATS; DIABETES MELLITUS; DIETARY CARBOHYDRATES; FEMALE; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, LONG-ACTING; MALE; PROTAMINES; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 67650699191     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2009.05.016     Document Type: Article

References (21)

1. Panciera D.L., Thomas C.B., Eicker S.W., and Atkins C. Epizootiologic patterns of diabetes mellitus in cats: 333 cases (1980-1986). J Am Vet Med Assoc 197 (1990) 1504-1508
2. Rand J.S., Bobbermein L.M., and Hendrikz J.K. Over-representation of Burmese in cats with diabetes mellitus in Queensland. Austral Vet J 75 (1997) 402-405
3. Baral R.M., Rand J.S., Catt M.J., and Farrow H.A. Prevalence of feline diabetes mellitus in a feline private practice. J Vet Int Med 17 (2003) 433-434
4. Bennett N., Greco D.S., Peterson M.E., Kirk C., Mathes M., and Fettman M.J. Comparison of a low carbohydrate-low fiber diet and a moderate carbohydrate-high fiber diet in the management of feline diabetes mellitus. J Feline Med Surg 8 (2006) 73-84
5. Martin G., and Rand J.S. Pharmacology of a 40 IU/ml porcine lente insulin preparation in diabetic cats. Findings during the first week and after five or nine weeks of therapy. J Feline Med Surg 3 (2001) 23-30
6. Marshall R.D., Rand J.S., and Morton J.M. Glargine and protamine zinc insulin have a longer duration of action and result in lower mean daily glucose concentrations than lente insulin in healthy cats. J Vet Pharmacol Therapeut 31 (2008) 205-212
7. Weaver K.E., Rozanski E.A., Mahony O.M., Chan D.L., and Freeman L.M. Use of glargine and lente insulins in cats with diabetes mellitus. J Vet Int Med 20 (2006) 234-248
8. Roomp K., and Rand J.S. Factors predictive of non-insulin dependence in diabetic cats initially treated with insulin. [Abstract]. J Vet Int Med 22 (2008) 696 (In review as: Intensive blood glucose control is safe and effective in diabetic cats using home monitoring and treatment with glargine J Feline Med Surg)
9. Sieber-Ruckstuhl N.S., Kley S., Tschuor F., et al. Remission of diabetes mellitus in cats with diabetic ketoacidosis. J Vet Intern Med 22 (2008) 1326-1332
10. Wade C., Gething M., and Rand J.S. Evidence of a genetic basis for diabetes mellitus in Burmese cats. [Abstract]. J Vet Int Med 13 (1999) 269
11. McCann T.M., Simpson K.E., Shaw D.J., Butt J.A., and Gunn-Moore D.A. Feline diabetes mellitus in the UK: the prevalence within an insured cat population and a questionnaire-based putative risk factor analysis. J Feline Med Surg 9 (2007) 289-299
12. Farrow H.A., Rand J.S., and Sunvold G.D. The effect of high protein, high fat or high carbohydrate diets on postprandial glucose and insulin concentrations in normal cats. [Abstract]. J Vet Int Med 16 (2002) 360
13. Service F.J., and Nelson R.L. Characteristics of glycemic stability. Diabetes Care 3 (1980) 58-62
14. Rossetti L., Giaccari A., and DeFronzo R.A. Glucose toxicity. Diabetes Care 13 (1990) 610-630
15. Unger R.H., and Grundy S. Hyperglycemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia 28 (1985) 119-121
16. Fulcher G.R., Gilbert R.E., and Yue D.K. Glargine is superior to NPH for improving glycated hemoglobin and fasting blood glucose levels during intensive insulin therapy. Int Med J 35 (2005) 536-542
17. Fonseca V., Bell D.S., Berger S., Thomson S., and Mecca T.E. A comparison of bedtime insulin glargine with bedtime Neutral protamine Hagedorn in patients with type 2 diabetes: subgroup analysis of patients taking once-daily insulin in a multicenter, randomized, parallel group study. Am J Med Sci 328 (2004) 274-280
18. Marshall R.D., Rand J.S., and Morton J.M. Insulin glargine has a long duration of effect following administration either once daily or twice daily in divided doses in healthy cats. J Feline Med Surg 10 (2008) 488-494
19. Martin G., and Rand J. Control of diabetes mellitus in cats with porcine insulin zinc suspension. Vet Rec 161 (2007) 88-93
20. Michiels L., Reusch C.E., Boari A., Petrie G., Mandigers P., Thollot I.G., et al. Treatment of 46 cats with porcine lente insulin - a prospective, multicentre study. J Feline Med Surg 10 (2008) 439-451
21. Rand J.S. Current understanding of feline diabetes: part 1, pathogenesis. J Feline Med Surg 1 (1999) 143-153